Aptar Pharma Inaugurates Congers Site Expansion, Supports Growth in Three Directions
Aptar Pharma’s site expansion in Congers, NY, was inaugurated on March 20 by
Stephan Tanda, AptarGroup’s President and CEO, Salim Haffar, President of Aptar Pharma, and Alex Theodorakis, President Aptar Pharma North America. Several Aptar Pharma customers in North America had been invited to attend this inaugural event.
Aptar Pharma’s newly-expanded, state-of-the-art manufacturing capabilities will be used to complete premium injectable elastomeric component manufacturing, enabling Aptar Pharma to better serve its North American pharmaceutical customers.
“The new expansion supports growth in three directions,” explained Bas van Buijtenen, President, Injectables Division, Aptar Pharma. “It adds capacity to our network of global manufacturing sites and will be equipped with the latest technologies to meet growing quality requirements. The proximity to our North American customer base improves our service and responsiveness.”
Following the event, Aptar Pharma welcomed current and future customers and partners during the Drug, Chemical & Associated Technologies Association (DCAT) Week and Interphex, at booth 1734.
Aptar Pharma is a part of the AptarGroup family of companies, along with Aptar Beauty + Home and Aptar Food + Beverage. AptarGroup, Inc. is a leading global supplier of a broad range of innovative dispensing and sealing solutions for the beauty, personal care, home care, prescription drug, consumer healthcare, injectables, food, and beverage markets. AptarGroup is headquartered in Crystal Lake, IL, with manufacturing facilities in North America, Europe, Asia, and South America. For more information, visit aptar.com/pharma.
Total Page Views: 3164
